Mycobacterium tuberculosis hijacks host macrophages-derived interleukin 16 to block phagolysosome maturation for enhancing intracellular growth

Haibo Su,Shufeng Weng,Liulin Luo,Qin Sun,Taiyue Lin,Huixia Ma,Yumo He,Jing Wu,Honghai Wang,Wenhong Zhang,Ying Xu
DOI: https://doi.org/10.1080/22221751.2024.2322663
2024-03-05
Emerging Microbes & Infections
Abstract:The discovery of promising cytokines and clarification of their immunological mechanisms in controlling the intracellular fate of Mycobacterium tuberculosis (Mtb) are necessary to identify effective diagnostic biomarkers and therapeutic targets. To escape immune clearance, Mtb can manipulate and inhibit the normal host process of phagosome maturation. Phagosome maturation arrest by Mtb involves multiple effectors and much remains unknown about this important aspect of Mtb pathogenesis. In this study, we found that interleukin 16 (IL-16) is elevated in the serum samples of Tuberculosis (TB) patients and can serve as a specific target for treatment TB. There was a significant difference in IL-16 levels among active TB, latent TB infection (LTBI), and non-TB patients. This study first revealed that macrophages are the major source of IL-16 production in response to Mtb infection, and elucidated that IL-16 can promote Mtb intracellular survival by inhibiting phagosome maturation and suppressing the expression of Rev-erbα which can inhibit IL-10 secretion. The experiments using zebrafish larvae infected with M. marinum and mice challenged with H37Rv demonstrated that reducing IL-16 levels resulted in less severe pathology and improved survival, respectively. In conclusion, this study provided direct evidence that Mtb hijacks the host macrophages-derived interleukin 16 to enhance intracellular growth. It is suggesting the immunosuppressive role of IL-16 during Mtb infection, supporting IL-16 as a promising therapeutic target.
immunology,infectious diseases,microbiology
What problem does this paper attempt to address?
The paper primarily explores how Mycobacterium tuberculosis (Mtb) manipulates the production of Interleukin 16 (IL-16) by host macrophages to inhibit phagolysosome maturation, thereby enhancing its intracellular growth. Specifically, the study found: 1. **Increased IL-16 levels**: The serum samples of patients with active pulmonary tuberculosis showed significantly elevated levels of IL-16, with notable differences compared to patients with Latent Tuberculosis Infection (LTBI) and non-tuberculosis individuals. 2. **Main source of IL-16**: The study confirmed that macrophages are the main producers of IL-16. After Mtb infection, the secretion of IL-16 in macrophages increased. 3. **Mechanism of IL-16 action**: IL-16 can promote the survival of Mtb within macrophages by inhibiting the maturation of phagolysosomes, thereby preventing the bacteria from being cleared. Additionally, IL-16 can further affect the immune response by inhibiting the expression of Rev-erbα. 4. **Impact of IL-16 on disease progression**: Studies on zebrafish larvae and mouse models found that reducing IL-16 levels can alleviate pathological damage and improve survival rates. In summary, this paper reveals the important role of IL-16 in the process of Mtb infection, providing a theoretical basis for developing new therapeutic targets.